UBS O'Connor’s CyrusOne Inc Common Stock CONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,175,766
Closed -$464M 1207
2021
Q4
$464M Buy
+5,175,766
New +$439M 4.47% 5
2017
Q1
Sell
-68,109
Closed -$3.05M 504
2016
Q4
$3.05M Buy
68,109
+15,917
+30% +$705K 0.06% 269
2016
Q3
$2.48M Buy
+52,192
New +$2.7M 0.04% 290
2016
Q2
Sell
-20,231
Closed -$923K 543
2016
Q1
$923K Sell
20,231
-39,769
-66% -$1.52M 0.01% 367
2015
Q4
$2.25M Sell
60,000
-40,000
-40% -$1.41M 0.02% 307
2015
Q3
$3.27M Buy
+100,000
New +$3.18M 0.03% 325
2015
Q2
Sell
-29,810
Closed -$928K 963
2015
Q1
$928K Buy
29,810
+14,905
+100% +$440K 0.01% 533
2014
Q4
$411K Buy
+14,905
New +$391K 0.01% 465

Other funds holding CONE

UBS O'Connor's CONE Position: Q1 2022 in Review

UBS O'Connor sold out of CyrusOne Inc Common Stock (CONE) in Q1 2022, closing a stake of 5,175,766 shares — an estimated $464M sold.

UBS O'Connor first reported a position in CONE in Q4 2014 and held it in 8 quarters. The position peaked at $464M in Q4 2021. 3 funds tracked by Wall St. Rank hold CONE as of Q1 2022.

  • UBS O'Connor reported no remaining CyrusOne Inc Common Stock position as of Q1 2022 after selling out during the quarter.
  • UBS O'Connor sold 5,175,766 CyrusOne Inc Common Stock shares in Q1 2022, an estimated $464M.
  • UBS O'Connor first reported a position in CyrusOne Inc Common Stock in Q4 2014 and held it in 8 quarters.
  • UBS O'Connor's CyrusOne Inc Common Stock position peaked at $464M in Q4 2021.
  • 3 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q1 2022.

Based on UBS O'Connor's 13F filing for Q1 2022, filed 16 May 2022.